Although it entered phase 1 trials in consideration as a treatment of ulcerative colitis, it has not been approved by the US Food and Drug Administration (FDA) for medical use, and data on human subjects is lacking
In some cases, users may experience mild flu-like symptoms fatigue, headache, nausea especially at the onset of treatment
People online now report that BPC-157 flattens their mood and dulls their stimulant medication
This includes finding at-risk groups, using preventive tests, and making lifestyle changes to better absorb nutrients
The peptide influences both endothelial nitric oxide synthase (eNOS), which produces the beneficial, vasodilating form of nitric oxide, and inducible nitric oxide synthase (iNOS), which can produce excessive amounts that contribute to inflammation and tissue damage
GHK-Cu is a synthetic peptide extensively studied for its potential applications in tissue regeneration, cellular repair, and molecular biology research